<DOC>
	<DOCNO>NCT02338856</DOCNO>
	<brief_summary>The purpose study investigate safety tolerability MB12066 multiple dose investigate pharmacokinetic characteristic MB12066 multiple dose .</brief_summary>
	<brief_title>Safety , Tolerability Pharmacokinetic Study MB12066 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Subject inform investigational nature study voluntarily agree participate study sign Institutional Review Board ( IRB ) approve informed consent prior perform screen procedure Healthy Korean male volunteer , age range 20 45 year A subject body weight 60 kg ( inclusive ) 90 kg ( exclusive ) body mass index ( BMI ) 18.5 ( inclusive ) 25 ( exclusive ) . ☞ BMI ( kg/m2 ) = weight ( kg ) / { height ( ) } 2 Findings within range clinical acceptability medical history physical examination , laboratory result within laboratory reference range relevant laboratory test ( unless investigator considers deviation irrelevant purpose study ) A subject history allergy include drug allergy ( aspirin , antibiotic , etc . ) , history clinically significant allergy A subject clinical evidence history hepatic ( include carrier hepatitis virus ) , renal , respiratory , endocrine , neurologic , immunologic , hematologic , oncologic , psychiatric , cardiovascular disease A subject history gastrointestinal disease surgery ( except simple appendectomy repair hernia ) , influence absorption study drug A subject whose hemoglobin ( Hb ) level &lt; 12 g/dL A subject fasting plasma glucose ( FPG ) level &lt; 70 mg/dL ≥ 126 mg/dL A subject whose systolic blood pressure ( SBP ) ≤ 90 mmHg ≥ 140 mmHg , diastolic blood pressure ( DBP ) ≤ 40 mmHg ≥ 90 mmHg pulse rate ( PR ) ≥ 100 /min least 5 min sit A subject history drug abuse A subject take prescribed medication herbal compound within 14 day prior study drug administration . In addition , subject take overthecounter drug vitamin supplement within 7 day prior study drug administration ( However , investigator judge subject , take medication period , eligible trial condition satisfy . ) A subject participate clinical trial either investigational market drug within 8 week study drug administration A subject donate loss ≥ 400 mL blood within 8 week prior start administration study drug A subject consumes 21 unit alcohol per week unable stop drinking throughout study period A smoker ( except quit smoking prior drug administration least 3 month ) A subject heavily take caffeine caffeinecontaining product , grapefruit , grapefruit juice , grapefruitcontaining product A subject unusual dietary habit A subject previously assign treatment study The investigator judge subject eligible study review clinical laboratory result reason</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Obesity</keyword>
</DOC>